Lexology August 23, 2022
Hogan Lovells

A newly released audit by the Office of Inspector General (OIG) found that for clinical trials funded by the National Institutes of Health (NIH) for which responsible parties were required to submit results to ClinicalTrials.gov in 2019 or 2020, a majority did not have their results timely submitted. As a result, OIG has recommended that NIH take additional enforcement actions against responsible parties that fail to meet their clinical trial reporting requirements, and NIH has responded that it is enhancing its abilities to track ClinicalTrials.gov non-compliance for its studies.

Federal law requires responsible parties (typically clinical trial sponsors) to submit results for their studies registered on ClinicalTrials.gov, generally no later than one year after the study’s completion date. However, according...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Clinical Trials, FDA, Govt Agencies, OIG, Survey / Study, Trends
OIG report finds just 40% of Medicare enrollees who started treatment for opioid use disorder continued
Patient Assistance Programs - The Dos and Don’ts from HHS OIG
HHS OIG Report Finds that CMS Made Additional Risk-Adjusted Payments Related to Health Risk Assessments
What makes a drug “special”?
Watchdog flags flaws in FDA's fast-track drug approvals

Share This Article